Hong, J. Y., Lim, H. Y., Kwon, M., Lee, S. Y., Lee, S., Yun, H., Hwang, S., Hwang, W., Kim, S. H., Kim, H. T. (2025). Phase 1b dose extension study of a next-generation anti-CD47 monoclonal antibody IMC-002 combined with lenvatinib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2526